Continuous Glucose Monitoring Systems Market Research Report Information by Product (Sensors, And Transmitter and Receivers), By Application (Type 2, Type 1, Non-diabetic Patients), By End User (Hospitals & Clinics, Homecare Settings, And Others), by Region (North America, Europe, Asia-Pacific, and Rest of the World) Forecast till 2032
Market Overview
In 2023, the market for continuous glucose monitoring systems was estimated to be worth USD 8.8 billion. The Continuous Glucose Monitoring Systems Market is expected to increase from USD 10.0 billion in 2024 to USD 25.8 billion by 2032, with a compound yearly growth rate (CAGR) of 12.34% over the forecast period (2024-2032).
The rising prevalence of diabetes worldwide is a major factor driving the growth of the Continuous Glucose Monitoring Systems Market. Diabetes has reached epidemic proportions, with a dramatic increase in the number of affected people worldwide. According to the International Diabetes Federation (IDF), there were roughly 537 million diabetics globally in 2021, with the figure predicted to rise to 643 million by 2030. Similarly, the American Diabetes Association estimates that diabetes will afflict 38.4 million Americans, or 11.6% of the population, by 2021. Type 1 diabetes affects roughly 2.0 million Americans, including 304,000 children and adolescents. Diabetes is becoming more common as a result of sedentary lifestyles, poor dietary habits, and an aging population. As the diabetic population grows, the need for appropriate diabetes control options becomes increasingly urgent.
Market Segment insights
The Continuous Glucose Monitoring Systems Market Segmentation by Product covers sensors, transmitters, and receivers.
The market is segmented by application, which includes type 2 diabetes, type 1 diabetes, and non-diabetic individuals.
The market is segmented by end user, which includes hospitals and clinics, homecare settings, and others.
Regional insights
The study divides the market into four regions: North America, Europe, Asia-Pacific, and the rest of the world. North America the Continuous Glucose Monitoring Systems market held the biggest market share in 2023. This is due to the robust technology infrastructure and well-established regulatory framework, which are projected to boost the market.
Europe's Continuous Glucose Monitoring Systems market is the second largest, owing to the region's rising diabetes prevalence and advances in CGM technology. Furthermore, the France Continuous Glucose Monitoring Systems market was ascribed to hold the biggest market share, while the Rest of Europe Continuous Glucose Monitoring Systems market is predicted to be the fastest-growing market in the European area.
The Asia-Pacific Continuous Glucose Monitoring Systems market is predicted to develop significantly between 2023 and 2032. This is attributable to increased diabetes management awareness and the region's rising diabetes prevalence. Furthermore, China Continuous Glucose Monitoring Systems market is predicted to hold the greatest market share, followed by India. The Continuous Glucose Monitoring Systems market is predicted to be the fastest growing in the Asia-Pacific region.
The Rest of the World is divided into two regions: the Middle East and Africa, and Latin America. The Continuous Glucose Monitoring Systems market in the regions is expected to develop due to the rising prevalence of diabetes, as well as increased awareness of improved glucose monitoring systems, which supports market expansion.
Major Players
Dexcom, Inc (US), Menarini Diagnostics SRL (Italy), Sensonics (US), Medtrum Technologies Inc. (China), Nemaura Medical Inc. (US), Ultrahuman Healthcare Pvt Ltd (India), Medtronic (Ireland), One Drop (US), Abbott Laboratories, Inc. (US), and Sinocare (China) are among the key players in the Continuous Glucose Monitoring Systems Market.
圖表清單 List of Tables & Figures
LIST OF TABLES
TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT
TABLE 2 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 3 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR SENSORS, BY REGION, 2019–2032 (USD MILLION)
TABLE 4 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR TRANSMITTER & RECEIVERS, BY REGION, 2019–2032 (USD MILLION)
TABLE 5 GLOBAL: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 6 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 2 DIABETES, BY REGION, 2019–2032 (USD MILLION)
TABLE 7 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR TYPE 2 DIABETES, BY REGION, 2019–2032 (USD MILLION)
TABLE 8 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR NON-DIABETIC PATIENTS, BY REGION, 2019–2032 (USD MILLION)
TABLE 9 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 10 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR WEIGHT LOSS, BY REGION, 2019–2032 (USD MILLION)
TABLE 11 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR DIET MANAGEMENT, BY REGION, 2019–2032 (USD MILLION)
TABLE 12 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET HEALTH & WELLNESS, BY REGION, 2019–2032 (USD MILLION)
TABLE 13 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 14 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2019–2032 (USD MILLION)
TABLE 15 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR HOMECARE SETTINGS, BY REGION, 2019–2032 (USD MILLION)
TABLE 16 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR OTHERS, BY REGION, 2019–2032 (USD MILLION)
TABLE 17 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2019–2032 (USD MILLION)
TABLE 18 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2019–2032 (USD MILLION)
TABLE 19 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 20 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 21 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 22 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 23 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 24 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 25 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 26 US: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 27 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 28 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 29 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 30 CANADA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 31 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2019–2032 (USD MILLION)
TABLE 32 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 33 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 34 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 35 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 36 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 37 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 38 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 39 GERMANY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 40 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 41 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 42 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 43 FRANCE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 44 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 45 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 46 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 47 UK: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 48 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 49 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 50 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 51 ITALY: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 52 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 53 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 54 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 55 SPAIN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 56 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 57 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 58 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 59 REST OF EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 60 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2019–2032 (USD MILLION)
TABLE 61 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 62 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 63 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 64 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019–2032 (USD MILLION)
TABLE 65 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 66 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 67 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 68 CHINA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019–2032 (USD MILLION)
TABLE 69 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 70 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 71 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 72 INDIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019–2032 (USD MILLION)
TABLE 73 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 74 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 75 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 76 JAPAN: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019–2032 (USD MILLION)
TABLE 77 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 78 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 79 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 80 SOUTH KOREA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019–2032 (USD MILLION)
TABLE 81 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 82 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 83 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 84 AUSTRALIA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019–2032 (USD MILLION)
TABLE 85 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 86 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 87 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 88 REST OF ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019–2032 (USD MILLION)
TABLE 89 REST OT THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2019–2032 (USD MILLION)
TABLE 90 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 91 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 92 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 93 REST OF THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019–2032 (USD MILLION)
TABLE 94 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 95 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 96 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 97 MIDDLE EAST & AFRICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019–2032 (USD MILLION)
TABLE 98 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2019–2032 (USD MILLION)
TABLE 99 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 100 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FOR NON-DIABETIC PATIENTS, BY TYPE, 2019–2032 (USD MILLION)
TABLE 101 LATIN AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET BY END USER, 2019–2032 (USD MILLION)
TABLE 102 PUBLIC PLAYERS STOCK SUMMARY
TABLE 103 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
TABLE 104 PRODUCT LAUNCH/PRODUCT APPROVAL
TABLE 105 AGREEMENT
TABLE 106 PERTNERSHIP
TABLE 107 COLLABORATION
TABLE 108 DEXCOM, INC: PRODUCT OFFERED
TABLE 109 DEXCOM, INC: KEY DEVELOPMENTS
TABLE 110 A. MENARINI DIAGNOSTICS SRL: PRODUCT OFFERED
TABLE 111 A. MENARINI DIAGNOSTICS SRL: KEY DEVELOPMENTS
TABLE 112 SENSEONICS: PRODUCT OFFERED
TABLE 113 SENSEONICS: KEY DEVELOPMENTS
TABLE 114 MEDTRUM TECHNOLOGIES INC.: PRODUCTS OFFERED
TABLE 115 NEMAURA MEDICAL INC.: PRODUCTS OFFERED
TABLE 116 NEMAURA MEDICAL INC.: KEY DEVELOPMENTS
TABLE 117 ULTRAHUMAN HEALTHCARE PVT LTD.: PRODCUTS OFFERED
TABLE 118 MEDTRONIC: PRODUCTS OFFERED
TABLE 119 MEDTRONIC: KEY DEVELOPMENTS
TABLE 120 ONE DROP: PRODUCTS OFFERED
TABLE 121 ABBOTT LABORATORIES, INC.: PRODUCTS OFFERED
TABLE 122 ABBOTT LABORATORIES, INC.: KEY DEVELOPMENTS
TABLE 123 SINOCARE: PRODUCTS OFFERED
TABLE 124 NUTRISENSE: PRODUCTS OFFERED
TABLE 125 NEMAURA MEDICAL INC.: PRODUCTS OFFERED
TABLE 126 SIGNOS INC.: PRODUCTS OFFERED
TABLE 127 LEVELS: PRODUCTS OFFERED
TABLE 128 VERI: PRODUCTS OFFERED
TABLE 129 LUMEN: PRODUCTS OFFERED
TABLE 130 JANUARY.AI: PRODUCTS OFFERED
LIST OF FIGURES
FIGURE 1 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET: STRUCTURE
FIGURE 2 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032)
FIGURE 3 DRIVER IMPACT ANALYSIS (2024-2032)
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2032)
FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET
FIGURE 6 PORTER’S FIVE FORCES ANALYSIS: GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET
FIGURE 7 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY PRODUCT, 2023 & 2032 (USD MILLION)
FIGURE 8 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, SHARE (%), BY PRODUCT, 2023
FIGURE 9 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY APPLICATION, 2023 & 2032 (USD MILLION)
FIGURE 10 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, SHARE (%), BY APPLICATION, 2023
FIGURE 11 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2023 & 2032 (USD MILLION)
FIGURE 12 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, SHARE (%), BY END USER, 2023
FIGURE 13 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY REGION, 2023 (% SHARE)
FIGURE 14 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2023 & 2032 (USD MILLION)
FIGURE 15 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
FIGURE 16 NORTH AMERICA: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 17 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
FIGURE 18 EUROPE: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 19 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)
FIGURE 20 ASIA-PACIFIC: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE (%), BY COUNTRY, 2023
FIGURE 21 REST OT THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2023 & 2032 (USD MILLION)
FIGURE 22 REST OT THE WORLD: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE (%), BY REGION, 2023
FIGURE 23 GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET PLAYERS: COMPETITIVE ANALSIS, 2023
FIGURE 24 COMPETITOR DASHBOARD: GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET
FIGURE 25 DEXCOM, INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 DEXCOM, INC: SWOT ANALYSIS
FIGURE 27 SENSEONICS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 NEMAURA MEDICAL INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 29 NEMAURA MEDICAL INC.: SWOT ANALYSIS
FIGURE 30 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 31 MEDTRONIC: SWOT ANALYSIS
FIGURE 32 ONE DROP: SWOT ANALYSIS
FIGURE 33 ABBOTT LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 34 ABBOTT LABORATORIES INC.: SWOT ANALYSIS
LIST OF FIGURES
FIGURE 1 GLOBAL DIGITAL HEALTH MARKET: STRUCTURE
FIGURE 2 GLOBAL DIGITAL HEALTH MARKET: MARKET GROWTH FACTOR ANALYSIS (2024-2032)
FIGURE 3 DRIVER IMPACT ANALYSIS (2024-2032)
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2024-2032)
FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL DIGITAL HEALTH MARKET
FIGURE 6 PORTER’S FIVE FORCES ANALYSIS: GLOBAL DIGITAL HEALTH MARKET
FIGURE 7 GLOBAL DIGITAL HEALTH MARKET, BY TECHNOLOGY, SEGMENT ATTRACTIVENESS, 2024-2032 (USD MILLION)
FIGURE 8 GLOBAL DIGITAL HEALTH MARKET, BY TECHNOLOGY, 2023 & 2032 (USD MILLION)
FIGURE 9 GLOBAL DIGITAL HEALTH MARKET SHARE (%), BY TECHNOLOGY, 2023
FIGURE 10 GLOBAL DIGITAL HEALTH MARKET, BY COMPONENT, SEGMENT ATTRACTIVENESS, 2024-2032 (USD MILLION)
FIGURE 11 GLOBAL DIGITAL HEALTH MARKET, BY COMPONENT, 2023 & 2032 (USD MILLION)
FIGURE 12 GLOBAL DIGITAL HEALTH MARKET SHARE (%), BY COMPONENT, 2023
FIGURE 13 GLOBAL DIGITAL HEALTH MARKET, APPLICATION SEGMENT ATTRACTIVENESS, 2023 & 2032 (USD MILLION)
FIGURE 14 GLOBAL DIGITAL HEALTH MARKET, END USER SEGMENT ATTRACTIVENESS, 2023 & 2032 (USD MILLION)
FIGURE 15 GLOBAL DIGITAL HEALTH MARKET, BY END USER, 2023 & 2032 (USD MILLION)
FIGURE 16 GLOBAL DIGITAL HEALTH MARKET SHARE (%), BY END USER, 2023
FIGURE 17 GLOBAL DIGITAL HEALTH MARKET SHARE, BY REGION, 2023 (% SHARE)
FIGURE 18 GLOBAL DIGITAL HEALTH MARKET, BY REGION, 2023 AND 2032 (USD MILLION)
FIGURE 19 NORTH AMERICA MARKET ANALYSIS: DIGITAL HEALTH MARKET, 2018-2032 (USD MILLION)
FIGURE 20 NORTH AMERICA: DIGITAL HEALTH MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
FIGURE 21 NORTH AMERICA: DIGITAL HEALTH MARKET, BY COUNTRY, 2023 & 20232 (USD MILLION)
FIGURE 22 EUROPE MARKET ANALYSIS: DIGITAL HEALTH MARKET, 2018-2032 (USD MILLION)
FIGURE 23 EUROPE: DIGITAL HEALTH MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
FIGURE 24 EUROPE: DIGITAL HEALTH MARKET, BY COUNTRY, 2023 AND 2032 (USD MILLION)
FIGURE 25 ASIA-PAIFIC MARKET ANALYSIS: DIGITAL HEALTH MARKET, 2018-2032 (USD MILLION)
FIGURE 26 ASIA-PAIFIC: DIGITAL HEALTH MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
FIGURE 27 ASIA-PAIFIC: DIGITAL HEALTH MARKET, BY COUNTRY, 2023 AND 2032 (USD MILLION)
FIGURE 28 REST OF THE WORLD MARKET ANALYSIS: DIGITAL HEALTH MARKET, 2018-2032 (USD MILLION)
FIGURE 29 REST OF THE WORLD: DIGITAL HEALTH MARKET SHARE, BY COUNTRY, 2023 (% SHARE)
FIGURE 30 REST OF THE WORLD: DIGITAL HEALTH MARKET, BY COUNTRY, 2023 AND 2032 (USD MILLION)
FIGURE 31 GLOBAL DIGITAL HEALTH MARKET PLAYERS: COMPETITIVE ANALSIS, 2023
FIGURE 32 COMPETITOR DASHBOARD: GLOBAL DIGITAL HEALTH MARKET
FIGURE 33 KONINKLIJKE PHILIPS N.V.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 34 ATHENAHEALTH: SWOT ANALYSIS
FIGURE 35 CISCO SYSTEMS, INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 36 EPIC SYSTEMS CORPORATION: SWOT ANALYSIS
FIGURE 37 NXGN MANAGEMENT, LLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 38 NXGN MANAGEMENT, LLC: SWOT ANALYSIS
FIGURE 39 MCKESSON CORPORATION: FINANCIAL OVERVIEW
FIGURE 40 GENERAL ELECTRIC COMPANY: SWOT ANALYSIS
FIGURE 41 GENERAL ELECTRIC COMPANY: FINANCIAL OVERVIEW
FIGURE 42 GENERAL ELECTRIC COMPANY: SWOT ANALYSIS
FIGURE 43 VERADIGM, LLC: FINANCIAL OVERVIEW SNAPSHOT
量子訊息有限公司為 Market Research Future 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們